1199 West Hasting Street
Suite 1400
Vancouver, BC V6E 3T5
Canada
949-505-5623
https://www.lobesciences.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Philip J. Young | CEO, Corporate Secretary & Chairman | 212.69k | N/D | 1957 |
Mr. Mathew Lee C.A., CPA | Chief Financial Officer | N/D | N/D | 1985 |
Mr. Baxter F. Phillips III, M.B.A. | COO & Director | N/D | N/D | 1975 |
Mr. Maghsoud Dariani | Chief Science Officer | N/D | N/D | 1955 |
Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
La calificación ISS Governance QuickScore de Lobe Sciences Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.